Trial Condition(s):

Peripheral Arterial Disease

Iloprost therapy in patients with critical limb ischemia

Bayer Identifier:

15439

ClinicalTrials.gov Identifier:

NCT01458041

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Monitoring efficacy and safety aspects of iv. iloprost therapy of patients with critical limb ischemia by recording clinical parameters.

Inclusion Criteria
- Patients who fulfill the internationally defined criteria of critical limb ischemia; 
 - Patients who are not eligible for vascular surgery or  angioplasty interventions and 
 - Patients who are treated with iloprost infusion.  
 - The treating physician has decided iloprost treatment before study enrollment.
Exclusion Criteria
- Exclusion criteria are in accordance with  the Summary of Product Characteristics of Ilomedin.

Trial Summary

Enrollment Goal
126
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Ilomedin (Iloprost, BAYQ6256)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Hungary

Status
Completed
 

Trial Design